Vandetanib efficacious in medullary thyroid cancer
Links shared publicly online about this topic.
- 876total visits
Vandetanib efficacious in medullary thyroid cancer
View full resource at endocrinetoday.com
Tags: Cancer, Thyroid Cancer, Medullary Thyroid Cancer
Most Recently Shared on September 13, 2010 at 10:16 pm By:
Vandetanib efficacious in medullary #thyroid cancer, according to study at Int'l Thyroid Congress http://ow.ly/2DFVs
Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial - OncologySTAT
oncologystat.com — “2011 Oct 24;[Epub Ahead of Print] - SA Wells Jr, BG Robinson, RF Gagel, H Dralle, JA Fagin, M Santoro, E Baudin, R Elisei, B Jarzab, JR Vasselli, J Read, P Langmuir, AJ Ryan, MJ Schlumberger” View full resource at oncologystat.com
Most Recently Shared on November 3, 2011 at 5:24 pm By:
OncologySTAT Oncology and Health Site
Story of the Week: Vandetanib Effective in Advanced Medullary Thyroid Cancer http://t.co/CA1KGTDj
CAPRELSA - New Product Releases - MPR
empr.com — “Symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease.” View full resource at empr.com
Most Recently Shared on August 5, 2011 at 3:04 pm By:
MPR News: CAPRELSA: Vandetanib 100mg, 300mg, tabs. http://bit.ly/qM5dba
AstraZeneca announces trade name CAPRELSA® for vandetanib
astrazeneca-us.com — “Visit the AstraZeneca U.S. Corporate Web site (www.astrazeneca-us.com) for more information.” View full resource at astrazeneca-us.com
Most Recently Shared on August 1, 2011 at 6:22 pm By:
Vandetanib now has a brand name: Caprelsa (medullary thyroid cancer drug) http://t.co/EXqkAEk
Symposier - Vandetanib Give Medullary Thyroid Cancer Patients A Second Chance
symposier.com — “Uploaded and shared in Youtube by: mdandersonorg — In April, the U.S. Food and Drug Administration approved the use of vandetanib for the treatment of medullary thyroid carcinoma. MD Anderson's Dr. Robert Gagel who with his team helped to bring about the FDA's approval of vandetanib talks about the drug, the research and it's benefit to medullary thyroid cancer patients.” View full resource at symposier.com
Most Recently Shared on May 25, 2011 at 3:25 pm By:
Symposier Endocrino Health Site
Vandetanib Give Medullary Thyroid Cancer Patients A Second Chance. http://bit.ly/mbMIhJ
Vandetanib Available for Advanced Medullary Thyroid Cancer - ONA
oncologynurseadvisor.com — “AstraZeneca has made available vandetanib for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease.” View full resource at oncologynurseadvisor.com
Most Recently Shared on April 25, 2011 at 7:05 pm By:
OncologyNurseAdvisor Nursing, Medical Education, Medical Publisher, and Oncology
Vandetanib Available for Advanced Medullary Thyroid Cancer http://goo.gl/fb/Z5ApL
AstraZeneca announces U.S. availability of vandetanib for rare medullary thyroid cancer
news-medical.net — “AstraZeneca today announced that the orphan drug vandetanib is now available to U.S. patients for the treatment of medullary thyroid cancer that cannot be removed by surgery or that has spread to other parts of the body.” View full resource at news-medical.net
Most Recently Shared on April 25, 2011 at 6:12 pm By:
News-Medical.Net Oncology and Health News
Oncology News: AstraZeneca announces U.S. availability of vandetanib for rare medullary thyroid cancer: AstraZen... http://bit.ly/fDCzBW
Vandetanib Available for Advanced Medullary Thyroid Cancer - MPR
empr.com — “AstraZeneca has made available vandetanib for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease.” View full resource at empr.com
Most Recently Shared on April 25, 2011 at 2:19 pm By:
MPR News: Vandetanib Available for Advanced Medullary Thyroid Cancer: AstraZeneca has made available vandetanib ... http://bit.ly/hxrm59
FDA Approves Orphan Drug Vandetanib for Advanced Medullary Thyroid Cancer
drugs.com — “Vandetanib is used to treat advanced medullary thyroid cancer. Includes vandetanib side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on April 11, 2011 at 12:50 am By:
FDA Approves Orphan Drug Vandetanib for Advanced Medullary Thyroid Cancer - http://bit.ly/hiHKy2
FDA Approves Orphan Drug Vandetanib For Advanced Medullary Thyroid Cancer
medicalnewstoday.com — “AstraZeneca (NYSE: AZN) has announced that the U.S. Food and Drug Administration (FDA) approved the orphan drug vandetanib for the treatment of medullary thyroid cancer that cannot be removed by s” View full resource at medicalnewstoday.com
Most Recently Shared on April 8, 2011 at 9:05 am By:
NatureRevEndocrinol Endocrinology and Medical Journal
RT @mnt_endocrine: FDA Approves Orphan Drug Vandetanib For Advanced Medullary Thyroid Cancer http://mnt.to/3Tpj #endocrinology
FDA Approves Vandetanib For Medullary Thyroid Cancer
medicalnewstoday.com — “Vandetanib has been approved by the FDA (Food and Drug Administration) for the treatment of late-stage medullary thyroid cancer in adults who cannot have surgery, and whose disease is progressing” View full resource at medicalnewstoday.com
Most Recently Shared on April 8, 2011 at 12:36 am By:
Ear, Nose, and Throat OW Health
FDA Approves Vandetanib For Medullary Thyroid Cancer: Vandetanib has been approved by the FDA (Food and Drug Adm... http://bit.ly/dQWJOu
FDA Approves Vandetanib for Metastatic Medullary Thyroid Cancer
onclive.com — “The FDA has approved vandetanib for the treatment of unresectable, late-stage, metastatic medullary thyroid cancer” View full resource at onclive.com
Most Recently Shared on April 7, 2011 at 9:48 pm By:
FDA Approves Vandetanib for Metastatic Medullary Thyroid Cancer http://goo.gl/MtWfZ
FDA Okays First Treatment for Rare Thyroid Cancer - QualityPoint Technologies
qualitypointtech.net — “WASHINGTON (MedPage Today) -- The FDA has approved vandetanib for treatment of metastatic medullary thyroid cancer in patients with growing or symptomatic disease who are ineligible for surgery.” View full resource at qualitypointtech.net
Most Recently Shared on April 7, 2011 at 9:00 pm By:
FDA Okays First Treatment for Rare Thyroid Cancer: WASHINGTON (MedPage Today) -- The FDA has approved vandetanib f... http://bit.ly/ftqNvm
Medical News: FDA Okays First Treatment for Rare Thyroid Cancer - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved vandetanib for treatment of metastatic medullary thyroid cancer in patients with growing or symptomatic disease who are ineligible for surgery.” View full resource at medpagetoday.com
Most Recently Shared on April 7, 2011 at 8:44 pm By:
FDA Okays First Treatment for Rare Thyroid Cancer http://bit.ly/hpX6ZE
Medical News: FDA Okays First Treatment for Rare Thyroid Cancer - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved vandetanib for treatment of metastatic medullary thyroid cancer in patients with growing or symptomatic disease who are ineligible for surgery.” View full resource at medpagetoday.com
Most Recently Shared on April 7, 2011 at 8:39 pm By:
FDA Okays First Treatment for Rare Thyroid Cancer: WASHINGTON (MedPage Today) -- The FDA has… http://goo.gl/fb/3BaXg
FDA Approves Vandetanib For Medullary Thyroid Cancer
medicalnewstoday.com — “Vandetanib has been approved by the FDA (Food and Drug Administration) for the treatment of late-stage medullary thyroid cancer in adults who cannot have surgery, and whose disease is progressing” View full resource at medicalnewstoday.com
Most Recently Shared on April 7, 2011 at 6:05 pm By:
MNT Drug Approvals Health News
FDA Approves Vandetanib For Medullary Thyroid Cancer http://mnt.to/3TmV #regulatory
Advertisement
